Skip to main content

Pig endogenous retrovirus – a threat to clinical xenotransplantation?: Review article

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Transplantation shows good results for patients with end-stage disease, but there is an increasing lack of organs. Xenotransplantation, the transfer of live animal cells, tissues, or organs to another species, offers a potential solution to this shortfall. Pig is regarded as the animal of choice for this purpose. Meanwhile demonstration of pig endogenous retrovirus (PERV) in all porcine herds has caused serious concern with respect to a possible transmission of the virus to humans with a transplanted organ. Transmission to human cells has been documented under certain in vitro conditions. However, no such transmission has been demonstrated in vivo. The possible consequences of introducing PERV into immunocompromised human organisms are not known and it is necessary to collect more information. Novel and sensitive genomic assays to detect PERV infection are now available in addition to established virological, immunoserological and molecular methods. In order to minimise the risk of PERV transmission rigorous procedures should be established. International guidelines to reduce the risk should be followed. Although a number of immunological, physiological and virological questions need to be answered before the introduction of xenotransplantation as an alternative clinical treatment, some problems can only be solved by judicious clinical trials.

Keywords: Pig endogenous retrovirus; clinical xenotransplantation; retrovirus transmission; risk

Document Type: Review Article

DOI: http://dx.doi.org/10.1034/j.1600-0463.2000.108004241.x

Affiliations: 1: Department of Cardiothoracic Surgery, The National Hospital, University of Oslo, 2: Institute of Microbiology, The National Hospital, University of Oslo, Oslo, Norway

Publication date: April 1, 2000

mksg/apm/2000/00000108/00000004/art00002
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more